BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CancerVax Corporation 

2110 Rutherford Road

Carlsbad  California  92008  U.S.A.
Phone: 760-494-4200 Fax: 760-431-9980


SEARCH JOBS










 Company News
Micromet Reports CancerVax Corporation (CNVX)'s First Quarter 2006 Financial Results 5/10/2006 6:20:21 PM
The Day In Review: Pfizer Inc. (PFE) Invests In Monogram Biosciences (MGRM) 5/8/2006 6:36:59 PM
Micromet And CancerVax Corporation (CNVX) Complete Merger To Form Micromet, Inc. 5/8/2006 5:06:14 PM
CancerVax Corporation (CNVX) To Host Conference Call And Live Webcast To Discuss First Quarter 2006 Financial Results And Merger With Micromet 5/8/2006 12:30:30 PM
CancerVax Corporation (CNVX) Stockholders Approve Merger With Micromet 5/4/2006 12:10:43 PM
The Day In Review: EPIX Pharmaceuticals (EPIX) Buys Predix Pharmaceuticals For $90 Million 4/4/2006 5:48:48 PM
CancerVax Corporation (CNVX) Presents Preclinical Data Demonstrating Tumor Inhibition By D93, A Novel Anti-Angiogenic Monoclonal Antibody 4/4/2006 2:13:02 PM
CancerVax Corporation (CNVX) Announces FDA Approval Of IND For Novel Anti-Angiogenic Antibody D93 4/3/2006 10:27:22 AM
CancerVax Corporation (CNVX) Announces Results Of Phase 3 Clinical Trials Of Canvaxin(TM) In Patients With Stage III And Stage IV Melanoma 3/24/2006 11:56:21 AM
CancerVax Corporation (CNVX) Drug Fails Late-Stage Skin Cancer Trial 3/24/2006 10:28:59 AM
12345678